Publications: 

Research articles:

1. Parmar MP, Kashyap S, Vala DP, Bhalodiya SS, Patel CD, Nogales J, Nandi A, Banerjee S, Patel Hitendra M Ethanol-Mediated One-Pot Synthesis of 3-Phenyl-3,4,5,12 tetrahydrobenzo [4,5]imidazo[2,1-b]quinazolin-1(2H)-ones as PDGFRA Inhibitors. Eur J Med Chem [Internet]. 2025;117914. 

2. Chowdhury, A., Maparu, K., Nandi, A., Das, A., Maji, H.S. and Jash, R., 2025. A study of Leonurine in chemically induced IgA nephropathy on Sprague Dawley rats. Natural Product Research, pp.1-7.

3. Parmar MP, Das A, Vala DP, Bhalodiya SS, Patel CD, Balachandran S, Kandukuri NK, Kashyap S, Khan AN, González-Bakker A, Arumugam MK, Padrón José M, Nandi A, Banerjee S, Patel Hitendra M. QSAR, Antimicrobial, and Antiproliferative Study of (R/S)-2-Thioxo-3, 4-dihydropyrimidine-5-carboxanilides. ACS Omega. 2025 Feb 10.

4. Nandi, A., Chattaraj, B., Das, A., Prasad, R. and Dey, Y.N., 2024. Inhibiting brushite crystal growth: molecular docking exploration of Enhydra fluctuans phytoconstituents and their interaction with human serum albumin. Journal of Biomolecular Structure and Dynamics, pp.1-10.

5. Jash, R., Maji, H.S., Chowdhury, A., Maparu, K., Seksaria, S., Gupta, P., Paria, A., Nandi, A., Das, A., Chattaraj, B. and Prasanth, D.S.N.B.K., 2024. Oxymatrine ameliorates epithelial mesenchymal transition in IgA nephropathy inducesssd rats. Tissue and Cell, p.102671.

6. Nandi, A., Mandal, N., Das, A. and Dey, Y.N., 2024. Approaches Based on Network Pharmacology and Molecular Docking to Predict the Molecular Mechanism of Plumbago zeylanica's Anti-Inflammatory Action. Journal of Biological Regulators and Homeostatic Agents, 38(3), pp.2055-2067.

7. Mahdi, Y.K., Mogana, R., Kumar, D., Nandi, A., Das, A., Atia, Y.A., Ranjan, R. and Dey, Y.N., 2023. In silico Molecular Docking and Scrutinizing Druglike Properties of Selected Phytoconstituents Against TAK1, Xanthin Oxidase, and IL-1 β Targets in Gouty Arthritis. Current Trends in Biotechnology and Pharmacy, 17(4), pp.1496-1505.

8. Nandi, A.#, Auti, P.S.#, Jagtap, U.A. and Paul, A.T., 2024. Investigating the role of indole and quinazolinone-based hybrid analogues with ketoamide fragment and alkyl extension for potential PL inhibition. Journal of Molecular Structure, 1301, p.137337.

9. Upadhyay, D.B., Mokariya, J.A., Patel, P.J., Patel, S.G., Das, A., Nandi, A., Nogales, J., More, N., Kumar, A., Rajani, D.P. and Narayan, M., 2024. Indole clubbed 2, 4‐thiazolidinedione linked 1, 2, 3‐triazole as a potent antimalarial and antibacterial agent against drug‐resistant strain and molecular modeling studies. Archiv der Pharmazie, p.e2300673.

10. Nandi, A., Nigar, T., Das, A. and Dey, Y.N., 2023. Network pharmacology analysis of Plumbago zeylanica to identify the therapeutic targets and molecular mechanisms involved in ameliorating hemorrhoids. Journal of Biomolecular Structure and Dynamics, pp.1-15.

11. Chattaraj, B., Nandi, A., Das, A., Baidya, A., Mahata, S., Chowdhury, A., Mitra, S., Roy, S., Chakraborty, S. and Dey, Y.N., 2023. Enhydra fluctuans Lour. aqueous extract inhibited the growth of calcium phosphate crystals: An in vitro study. Food Chemistry Advances, 2, p.100287.

12. Chattaraj, B., Khanal, P., Nandi, A., Das, A., Sharma, A., Mitra, S. and Dey, Y.N., 2023. Network pharmacology and molecular modelling study of Enhydra fluctuans for the prediction of the molecular mechanisms involved in the amelioration of nephrolithiasis. Journal of Biomolecular Structure and Dynamics, pp.1-11.

13. Nandi, A., Das, A., Dey, Y.N. and Roy, K.K., 2023. The Abundant Phytocannabinoids in Rheumatoid Arthritis: Therapeutic Targets and Molecular Processes Identified Using Integrated Bioinformatics and Network Pharmacology. Life, 13(3), p.700.

14. Chattaraj, B., Nandi, A., Das, A., Sharma, A., Dey, Y.N. and Kumar, D., 2023. Inhibitory activity of Enhydra fluctuans Lour. on calcium oxalate crystallisation through in silico and in vitro studies. Frontiers in pharmacology, 13, p.982419.

15. Auti, P.S.#, Nandi, A.#, Kumari, V. and Paul, A.T., 2022. Design, synthesis, biological evaluation and molecular modelling studies of oxoacetamide warhead containing indole-quinazolinone based novel hybrid analogues as potential pancreatic lipase inhibitors. New Journal of Chemistry, 46(24), pp.11648-11661.

Review articles:

1. Bej, A., Mandal, N., Das, A. and Nandi, A.*, 2025. Innovative approaches to blood-brain barrier modelling: The chip revolution. Next Nanotechnology, 7, p.100171.

2. Haj-Yahia, S.#, Nandi, A.# and Benhamou, R.I., 2023. Targeted Degradation of Structured RNAs via Ribonuclease-Targeting Chimeras (RiboTacs). Expert Opinion on Drug Discovery, (just-accepted).

3. Makhal, P.N., Nandi, A. and Kaki, V.R., 2021. Insights into the recent synthetic advances of organoselenium compounds. ChemistrySelect, 6(4), pp.663-679.

Book Chapters:

1. Shome, A., Das, A., and Nandi, A.*, Peptides and Enzyme Inhibitors in Drug Discovery. Academic Press (Elsevier), In press.

2. Chowdhury, N., Shome, A., Das, A., and Nandi, A.*, Pharmacophore-based approaches, screening and drug design. Taylor & Francis (CRC), In press.

3. Karmakar, S., Nigar, T., Das, A., Nandi, A.*, and Chander, S., Epilepsy: Real-time Monitoring with Biomarker and Biosensor Technology. Bentham Science Publishers, In Press.

4. Bej, A., Mandal, N., Das, A., and Nandi, A.*, Potential Applications of Microbiome Research in Other Areas of Gastroenterology. Academic Press (Elsevier), In press.

5. Katepaka, S., Bej, A., Das, A., and Nandi, A.*, Ethical Considerations and Privacy in AI-Driven Metaverse Healthcare. Academic Press (Elsevier), In press.

6. Seksaria, S., Saha, S., Das, A., and Nandi, A.*, Cognitive therapy for brain disease using deep learning models. Academic Press (Elsevier), In press.

7. Karmakar, S., Nigar, T., Das, A., Nandi, A., and Chander, S*, Epilepsy: Real-Time Monitoring with Biomarker and Biosensor Technology. Bentham Science Publishers, In press.

8. Seksaria, S., Saha, S., Gupta, P., Das, A., and Nandi, A.*, Cognitive therapy for brain disease using deep learning models. Academic Press (Elsevier), In press.

9. Gupta, P., Dutta, S., Chatterjee, D., Das, A., and Nandi, A.*, Nasal, transdermal delivery of probiotics. Academic Press (Elsevier), In press.

10. Mandal, N., Bej, A., Das, A., and Nandi, A.*, Stem Cells and Pyroptosis in Cardiac Injury. Academic Press (Elsevier), In press.

11. Mandal, N., Bej, A., Das, A., El-Shazly, M., and Nandi, A.*, Structural insights into pathological protein aggregates from amyloid fibrils to inclusion bodies. Academic Press (Elsevier), In press.

12. Dey, C., Nigar, T., Karmakar, S., Das, A., and Nandi, A.*, Nanotechnology in Dermatological Surgery and Aesthetic Procedures. Academic Press (Elsevier), In press.

13. Bej, A., Ghosh, A., Das, A., and Nandi, A.*, Nanoclays in ancient medical practice. Academic Press (Elsevier), In press.

14. Chattaraj, B., Nandi, A., Das, A., Hossain, M.A., and Lin, W.Y., Herb-Drug Interactions in Modern Healthcare. Bentham Science Publishers, In press.

15. Bej, A., Mandal, N., Das, A., and Nandi, A.*, Current advances on Gene Therapeutics using Nanocarriers for the treatment of Alzheimer’s disease. Taylor & Francis, In press.

16. Gupta, P., Seksaria, S., Saha, S., Das, A., Nandi, A., and Lin, W.Y., Exploring the Brain Architecture using Blue Brain Project. Taylor & Francis, In press.

17. Karmakar, S., Nigar, T., Das, A., and Nandi, A.*, Good Clinical Practices for Clinical Trials of Herbal Medicine. Taylor & Francis, In press.

18. Nigar, T., Dey, C., Das, A., and Nandi, A.*, Anticancer Properties of Plants from the Genus Securidaca. Taylor & Francis, In press.

19. Bej, A., Mandal, N., Das, A., Das, S., and Nandi, A.*, Medicinal and nutritional importance of Enhydra Fluctuans in human health. Springer, In press.

20. Das, S., Bej, A., Das, A., and Nandi, A.*, Ethical Considerations in Using Wearable Devices for Health Monitoring. Academic Press (Elsevier), In press.

21. Karmakar, S., Dey, C., Das, A., and Nandi, A.*, Antimicrobial Stewardship: Strategies, Challenges and Case Studies. Academic Press (Elsevier), In press.

22. Chattaraj, B., Nigar, T., Das, A., and Nandi, A.*, Recent updates on alternative approach to tackle AMR: secondary metabolites from natural source. Academic Press (Elsevier), In press.

23. Das, A., Mandal, N., and Nandi, A.*, Gepirone: A selective partial agonist of the 5-HT1A Receptor in the treatment of Depression. Academic Press (Elsevier), In press.

24. Mandal, N., Bej, A., Das, A., and Nandi, A.*, Tyrosine kinase as the therapeutic target for neurodegenerative diseases. Bentham Science Publishers, In press.

25. Bej, A., Mandal, N., Das, A., and Nandi, A.*, MicroRNAs in AD Management: Significant approaches as diagnostic biomarkers. Taylor & Francis, In press.

26. Bej, A., Das, A., Mandal, N., Dan, S., and Nandi, A.*, Biomaterial and micro-needling in cancer therapy. Bentham Science Publishers, In press.

27. Chattaraj, B., Das, A., Nandi, A., Das, A., Bej, A., and El-Shazly, Mohamed., Polysaccharides in cancer prevention. Taylor & Francis, In press.

28. Bej, A., Das, A., Nandi, A., Chattaraj, B., and El-Shazly, Mohamed., Polysaccharides in Targeted Therapy. Taylor & Francis, In press.

29. Bhattacharya, T., Tiwari, S., Nandi, A., Lin, W.Y., and Arumugam, S., Development of microRNA as prognostic markers in head and neck cancer. Academic Press (Elsevier), pp. 193-205.

30. Chattaraj, B., and Nandi, A., mi RNA theranostic roles in the ALS. Wiley, In press.

31. Chattaraj, B., Nandi, A., and Lin, W.Y., 2024. Role of the gallbladder in our metabolism and immune system. Academic Press (Elsevier), pp. 23-38.

32. Bhattacharya, T., Nandi, A., and Chander, S., 2024. Gallstone: a factor for acute pancreatitis. Academic Press (Elsevier), pp. 117-141.

33. Bhattacharya, T., Nandi, A., Das, A., and El-Shazly, Mohamed., 2024. Role of liver in gallstone formation. Academic Press (Elsevier), pp. 51-70.

34. Nandi, A., Dey, Y.N., Maity, D., and Das, A., Vaccine development strategies and impact. Academic Press (Elsevier), pp. 149-180.

35. Das, A.#, Nandi, A.#, Kumari, V., and Chander, S., 2024. Immunoinformatics in Drug Designing. Taylor & Francis, pp. 127-149.

36. Kumari, V.#, Nandi, A.#, Das, A., and Chander, S., 2024. Bioinformatics for Determining the Active Site of Target Proteins. Taylor & Francis, pp. 43-59.

37. Das, A., Nandi, A., Kumari, V., and Alvala, M., 2023. FBDD & De Novo Drug Design. Bentham Science Publishers, 1, pp.159-201.

38. Nandi, A., Das, A., Lin, W.Y., and Chakraborty, P., 2023. Antiviral Drugs - in Past and Current Pandemics. Bentham Science Publishers, 2, pp.167-194.

#Equal authorship

*Corresponding author